Published in J Hosp Infect on October 04, 2011
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol (2012) 2.45
Whole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells. PLoS One (2013) 1.20
Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis (2013) 1.08
Defining gene-phenotype relationships in Acinetobacter baumannii through one-step chromosomal gene inactivation. MBio (2014) 1.00
First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. Antimicrob Agents Chemother (2012) 0.97
Stress responses in the opportunistic pathogen Acinetobacter baumannii. Future Microbiol (2013) 0.93
Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob Agents Chemother (2013) 0.93
The role of surface disinfection in infection prevention. GMS Hyg Infect Control (2013) 0.93
Characterisation of pellicles formed by Acinetobacter baumannii at the air-liquid interface. PLoS One (2014) 0.93
Atomic force microscopy analysis of the Acinetobacter baumannii bacteriophage AP22 lytic cycle. PLoS One (2012) 0.86
Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii. Front Microbiol (2014) 0.84
Biofilm Formation and Quorum-Sensing-Molecule Production by Clinical Isolates of Serratia liquefaciens. Appl Environ Microbiol (2015) 0.84
Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cells. Virulence (2016) 0.84
Identification of genes essential for pellicle formation in Acinetobacter baumannii. BMC Microbiol (2015) 0.83
An ribonuclease T2 family protein modulates Acinetobacter baumannii abiotic surface colonization. PLoS One (2014) 0.83
Differential Role of the T6SS in Acinetobacter baumannii Virulence. PLoS One (2015) 0.82
Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces. Microbiology (2013) 0.81
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps. Antimicrob Agents Chemother (2015) 0.80
Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump. Antimicrob Agents Chemother (2015) 0.80
Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness. J Bacteriol (2015) 0.80
Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones. BMC Microbiol (2015) 0.76
Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates. Front Public Health (2016) 0.76
Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates. Pharmaceuticals (Basel) (2016) 0.76
Inactivation of Acinetobacter baumannii Biofilms on Polystyrene, Stainless Steel, and Urinary Catheters by Octenidine Dihydrochloride. Front Microbiol (2016) 0.75
Association of biofilm production with colonization among clinical isolates of Acinetobacter baumannii. Korean J Intern Med (2016) 0.75
Imipenem Treatment Induces Expression of Important Genes and Phenotypes in a Resistant Acinetobacter baumannii Isolate. Antimicrob Agents Chemother (2015) 0.75
Occurrence of an environmental Acinetobacter baumannii strain similar to a clinical isolate in paleosol from Croatia. Appl Environ Microbiol (2014) 0.75
An Entomopathogenic Nematode Extends Its Niche by Associating with Different Symbionts. Microb Ecol (2016) 0.75
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
[Estimation of the sample size in clinical and epidemiological investigations]. Med Clin (Barc) (1998) 2.18
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis]. Med Clin (Barc) (1998) 1.95
Nucleotide sequence of a 13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of fimbrial biosynthetic genes. Mol Microbiol (1993) 1.89
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect (2008) 1.73
Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg (2009) 1.72
Diarrhea in children under 5 years of age from Ifakara, Tanzania: a case-control study. J Clin Microbiol (2000) 1.72
Digestive anisakiasis: clinical manifestations and diagnosis according to localization. Rev Esp Enferm Dig (2002) 1.70
Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol (1999) 1.63
Dietary patterns and associated lifestyles in preconception, pregnancy and postpartum. Eur J Clin Nutr (2006) 1.58
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol (1998) 1.53
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49
Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43
Accuracy and reliability of pulse oximetry at different arterial carbon dioxide pressure levels. Eur Respir J (2008) 1.41
High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect (2007) 1.40
Ventilatory insufficiency due to asbestos-related diffuse pleural fibrosis successfully treated with noninvasive home mechanical ventilation. Respiration (2001) 1.40
Schinzel-Giedion syndrome: report of two sibs. Am J Med Genet (1995) 1.40
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother (1999) 1.39
[Diagnostic approach to neoplasms at an internal medicine service]. Med Clin (Barc) (1996) 1.39
Comparison of acquisition of resistant microorganisms and infections in critically-ill patients with and without malignancies. Minerva Anestesiol (2013) 1.38
Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38
[Athero-embolic nephropathy. Report of 2 cases]. Med Clin (Barc) (1990) 1.38
[Incidence of enteropathogens in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 1.38
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect (2005) 1.36
Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol (2007) 1.33
Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii. Int J Antimicrob Agents (2000) 1.33
Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr (2001) 1.28
CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.27
Cholera outbreak in southern Tanzania: risk factors and patterns of transmission. Emerg Infect Dis (2001) 1.27
Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis (2001) 1.26
Liver transplantation in patients with portal vein thrombosis. Liver Transpl (2001) 1.23
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 1.21
Correlation of six methods for typing nosocomial isolates of Acinetobacter baumannii. J Med Microbiol (1995) 1.17
Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study. Bone (1995) 1.17
Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect (2011) 1.14
Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother (2006) 1.14
Diamond-Blackfan syndrome: lymphocyte-mediated suppression of erythropoiesis. Science (1976) 1.13
Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect (2006) 1.11
Enteroaggregative Escherichia coli strains as a cause of traveler's diarrhea: a case-control study. J Infect Dis (1998) 1.11
A comparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS. Eur J Clin Microbiol Infect Dis (2011) 1.10
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol (2001) 1.07
Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain. Clin Microbiol Infect (2003) 1.05
Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance. J Med Microbiol (1999) 1.03
Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility. J Travel Med (1998) 1.03
Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol (2000) 1.03
Evolution of semen quality in North-eastern Spain: a study in 22,759 infertile men over a 36 year period. Hum Reprod (1999) 1.02
Acute delirium as a manifestation of obstructive sleep apnea syndrome. Am J Respir Crit Care Med (1998) 1.02
Synchronus renal cell carcinoma and Bellini duct carcinoma: a case report on a rare coincidence. World J Urol (2000) 1.02
Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium. J Med Microbiol (1997) 1.01
Intelligent telemonitoring of critical-care patients. IEEE Eng Med Biol Mag (1999) 1.01
Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study. J Intern Med (2003) 1.01
Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide. Lancet (1997) 1.00
The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J Antimicrob Chemother (1997) 1.00
Testicular self-examination: attitudes and practices among young men in Europe. Prev Med (1994) 0.99
Antimicrobial susceptibility and mechanisms of resistance to quinolones and beta-lactams in Acinetobacter genospecies 3. Antimicrob Agents Chemother (2004) 0.98
Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis (2005) 0.98
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Clin Microbiol Infect (2011) 0.98
First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. Antimicrob Agents Chemother (2012) 0.97
Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin Microbiol Infect (2007) 0.97
Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals. Antimicrob Agents Chemother (2004) 0.97
Spread of NDM-2-producing Acinetobacter baumannii in the Middle East. J Antimicrob Chemother (2013) 0.96
The development and validation of Spanish versions of the State and Trait Food Cravings Questionnaires. Behav Res Ther (2000) 0.96
The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae. Clin Microbiol Infect (2005) 0.96
Two chromosomally located qnrB variants, qnrB6 and the new qnrB16, in Citrobacter spp. isolates causing bacteraemia. Clin Microbiol Infect (2009) 0.95
Evaluation of two miniaturized systems, MicroScan W/A and BBL Crystal E/NF, for identification of clinical isolates of Aeromonas spp. J Clin Microbiol (2003) 0.95
Empirical solvation models in the context of conformational energy searches: application to bovine pancreatic trypsin inhibitor. Proteins (1992) 0.95
High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother (1995) 0.95
Prevalence of angina pectoris in Spain. PANES Study group. Eur J Epidemiol (1999) 0.95
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. J Antimicrob Chemother (1999) 0.94
Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus. Clin Microbiol Infect (2002) 0.94
Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int (2007) 0.94
Effect of smoking and smoking cessation on bone mass, bone remodeling, vitamin D, PTH and sex hormones. J Musculoskelet Neuronal Interact (2006) 0.93
Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity. Eur J Pharmacol (2001) 0.93
Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.93
Determination of D-lactate concentration for rapid diagnosis of bacterial infections of body fluids. Eur J Clin Microbiol Infect Dis (1991) 0.93
Tricuspid annular plane systolic excursion (TAPSE) in dogs: reference values and impact of pulmonary hypertension. J Vet Intern Med (2012) 0.92
[Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates]. Enferm Infecc Microbiol Clin (2006) 0.92
In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii. Clin Microbiol Infect (2011) 0.91
Prevalence of the set-1B and astA genes encoding enterotoxins in uropathogenic Escherichia coli clinical isolates. Microb Pathog (2009) 0.91
Development of in-vivo resistance after quinolone treatment of gonococcal urethritis. J Antimicrob Chemother (1997) 0.90
Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome. Eur Respir J (1998) 0.90
Epidemiological markers of Acinetobacter baumannii clinical isolates from a spinal cord injury unit. J Hosp Infect (1994) 0.90
Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones. J Antimicrob Chemother (2001) 0.89
Comparative study of virulence traits of Escherichia coli clinical isolates causing early and late neonatal sepsis. J Clin Microbiol (2007) 0.88
Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea. Clin Microbiol Infect (2004) 0.87
Focal dendritic swellings in Purkinje cells in mucopolysaccharidoses types I, II and III. A Golgi and ultrastructural study. Neuropathol Appl Neurobiol (1989) 0.87
Molecular characterization of the integrons in Shigella strains isolated from patients with traveler's diarrhea. Diagn Microbiol Infect Dis (2004) 0.87
[Validation of a respiratory polygraphy system in the diagnosis of sleep apnea syndrome]. Arch Bronconeumol (2005) 0.86
Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study. Atherosclerosis (2001) 0.85
Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta Obstet Gynecol Scand (1998) 0.85
Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals. Antiviral Res (1996) 0.85